CRISPR gene therapy, ultrasound and drugs team up against liver cancer
Researchers in China have developed a new three-pronged method to fight liver cancer that shows promise in tests in mice. The technique combines drugs and CRISPR-Cas9 gene editing into lipid nanoparticles, then activates them with ultrasound.
No comments:
Post a Comment